Intervention

Magnetic resonance imaging (MRI)

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 13 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials13

Recruiting4

Common conditions25

Lead sponsors shown12

Clinical trials

13 shown

Mirai-MRI: Validation of AI Models for Breast Cancer RiskNCT07121972 · 2025-11-03

RECRUITING

The Swedish BioFINDER - Preclinical AD StudyNCT06121544 · 2022-04-01

RECRUITING

The Swedish BioFINDER Sleep StudyNCT07533799 · 2021-10-01

RECRUITING

Early Pulmonary Dysfunction in Childhood Cancer PatientsNCT05427136 · 2021-06-01

RECRUITING

Biomarkers of Dementia in Chronic Sleep and Breathing DisordersNCT06377332 · 2023-12-01

UNKNOWN

Watchful Observation of Patients With LD-SCLC Instead of the PCINCT04168281 · 2019-09-02

UNKNOWN

Characterize Tumor Hypoxia by Magnetic Resonance ImagingNCT03987568 · 2019-07-10

WITHDRAWN

Is Lipid Mapping an Effective Early Detection Tool for Breast Cancer in High-risk Populations?NCT03949946 · 2019-06-20

COMPLETED

Microbiome Benchmarking to Identify Perturbations in Multiple Sclerosis IINCT03797937 · 2018-11-01

COMPLETED

68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing SurgeryNCT02678351 · 2016-04-18

COMPLETED

An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid ArthritisNCT01656278 · 2012-03-01

COMPLETED

Determinants of the Progression and Outcome of Mitral RegurgitationNCT01835054 · 2008-12-01

UNKNOWN

Cardiac Magnetic Resonance Imaging and Pulmonary PerfusionNCT01100008 · 2007-09-01

COMPLETED

Common conditions

Leading sponsors

Skane University Hospital2 Andrei Iagaru1 Laval University1 National MS Center Melsbroek1 Professor of Rheumatology, MD, DMSci, Kim Horslev-Petersen1 Sergiusz Nawrocki1 University Children's Hospital Basel1 University Hospital, Toulouse1 University of Aberdeen1 University of California, San Francisco1 Wake Forest University Health Sciences1 Woolcock Institute of Medical Research1

Trial status mix

COMPLETED5

RECRUITING4

UNKNOWN3

WITHDRAWN1

Phase mix

NA6

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.